Medlior’s Founder and President Tara Cowling was delighted to attend the CADTH Symposium 2023 in Ottawa last week. On the heels of the ISPOR 2023 conference, CADTH also tackled some key issues surrounding the use of RWE to inform decision-making.
Category
Insights
ISPOR 2023 in Boston
Hot-button items from the ISPOR 2023 conference included an emphasis on data quality, defining value, and caution with AI.
Treatment intensification and guideline LDL-C threshold achievement following acute myocardial infarction: Insights from a real-world evidence study
In a real-world Canadian population of high-risk patients with AMI, PCSK9i therapy in combination with other LLTs or alone was associated with better LDL-C reduction and higher proportions of patients meeting guideline thresholds; however, there was a longer time between the AMI event and PCSK9i treatments.
Accelerating access for rare diseases
For many rare diseases, the drug development process is particularly challenging. A multi-pronged approach to overcoming these challenges is underway.
2022: A Year in Review
As we slowly emerged from our COVID caves of 2020-2021, this year brought great excitement to Medlior. We helped industry bring life-changing innovations to market, and we increased our stakeholder collaboration.
Men’s Mental Health: A Silent Crisis
November is men’s health awareness month – and some of the less-often-talked about health issues affecting men are about their mental health. The Canadian Mental Health Association is calling this a “silent crisis, a sleeper issue”.
CADTH RWE Framework
I had the pleasure of attending the The Canadian Association for Population Therapeutics annual conference in Toronto, Canada. The program was titled “Embracing Change and Uncertainty to Improve the Health of Canadians” and it was kicked-off with a townhall session on Canadian RWE Initiatives…
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases Presentations: Trends in Osteoporotic Incidences and Care during the COVID-19 Pandemic
A real-world evidence study examining COVID-19 pandemic disruptions in osteoporosis care patterns and outcomes across Alberta, Canada, was presented through two posters at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Early Diagnosis of Alzheimer’s Disease Using AI Techniques in Primary Care
Alzheimer’s disease (AD) is a degenerative neurological disease with progressive death of brain cells, eventually leading to death.1,2 It is the most prevalent irreversible dementia, marked by deterioration of memory, judgement, and reasoning and worsening of mood, behaviour, communication, and function to perform daily activities.1 With longer life expectancy and an aging population, the burden of AD on the quality of life of patients and their family and caregivers is increasing.
Indigenous healthcare research in Canada—A changing landscape
With National Indigenous People’s Day on June 21st, Medlior is reflecting on health disparities for Indigenous peoples in Canada. First Nations, Inuit, and Métis people have typically been underrepresented in research studies, but there are promising signs of change.
